Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Aug 30;3(5669):487. doi: 10.1136/bmj.3.5669.487

Chemotherapy of drug-resistant tuberculosis.

PMCID: PMC1984316  PMID: 5801341

Full text

PDF

Page 487

487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canetti G., Le Lirzin M., Porven G., Rist N., Grumbach F. Some comparative aspects of rifampicin and isoniazid. Tubercle. 1968 Dec;49(4):367–376. doi: 10.1016/s0041-3879(68)80017-0. [DOI] [PubMed] [Google Scholar]
  2. Gyselen A., Verbist L., Cosemans J., Lacquet L. M., Vandenbergh E. Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis. Am Rev Respir Dis. 1968 Dec;98(6):933–941. doi: 10.1164/arrd.1968.98.6.933. [DOI] [PubMed] [Google Scholar]
  3. Horne N. W. Drug-resistant tuberculosis: a review of the world situation. Tubercle. 1969 Mar;50(Suppl):2–12. [PubMed] [Google Scholar]
  4. SOMNER A. R., BRACE A. A. Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis. Tubercle. 1962 Dec;43:345–360. doi: 10.1016/s0041-3879(62)80003-8. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES